Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001638599-18-001307

Director bought 11,764,705 shares at $17.00 ($199,999,985)

  • Director disposed of 489,977 shares (other)
  • Director acquired 143,294 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BAKER BROS. ADVISORS LP Director 2018-11-30 Purchase +585,882 $17.00 $9,959,994 3,736,902 I: show line 1 in the form
BAKER BROS. ADVISORS LP Director 2018-11-30 Purchase +11,178,823 $17.00 $190,039,991 35,976,940 I: show line 2 in the form
BAKER BROS. ADVISORS LP Director 2018-11-30 Other disposition −489,977 0 I: show line 3 in the form
BAKER BROS. ADVISORS LP Director 2018-11-30 Other acquisition +71,647 71,647 D: show line 4 in the form
BAKER BROS. ADVISORS LP Director 2018-11-30 Other acquisition +71,647 71,647 D: show line 5 in the form
Open-market purchases · 11,764,705 sh · avg $17.00 · $199,999,985

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BAKER BROS. ADVISORS LP Director 2018-11-30 Other disposition · Common Stock Warrant (right to buy) −10,731 0 I: show line 6 in the form
BAKER BROS. ADVISORS LP Director 2018-11-30 Other acquisition · Common Stock Warrant (right to buy) +1,569 1,569 D: show line 7 in the form
BAKER BROS. ADVISORS LP Director 2018-11-30 Other acquisition · Common Stock Warrant (right to buy) +1,569 1,569 D: show line 8 in the form
Loading xslF345X03/doc4_5797.xml…